Image Credit: STAT News

Alnylam enters the ATTR-CM drug race

Watchdoq March 21, 2025

Today in "The Readout" newsletter: Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.